We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

161 hedge funds and large institutions have $1.43B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 52 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

466% more call options, than puts

Call options by funds: $18.3M | Put options by funds: $3.23M

125% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 12

10% more funds holding

Funds holding: 147 → 161 (+14)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 52

8% less capital invested

Capital invested by funds: $1.56B → $1.43B (-$129M)

Holders
161
Holders Change
+14
Holders Change %
+9.52%
% of All Funds
2.82%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
27
Increased
52
Reduced
52
Closed
12
Calls
$18.3M
Puts
$3.23M
Net Calls
+$15.1M
Net Calls Change
+$10.9M

Top Buyers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
+$23.9M
2
EAM
Eventide Asset Management
Massachusetts
+$12.8M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$8.28M
4
SCM
Suvretta Capital Management
New York
+$6.69M
5
AC
Armistice Capital
New York
+$6.57M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$35.6M
2
DM
Deerfield Management
New York
-$16.9M
3
CCM
Consonance Capital Management
New York
-$14.2M
4
TCM
Tekla Capital Management
Massachusetts
-$11.3M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$8.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
26
Eventide Asset Management
Massachusetts
$13.6M +$12.8M +400,000 New
Alkeon Capital Management
27
Alkeon Capital Management
New York
$13.5M -$8.62M -270,200 -40%
HM
28
HealthCor Management
New York
$13.1M – – –
Norges Bank
29
Norges Bank
Norway
$12.5M -$314K -9,837 -3%
UBS AM
30
UBS AM
Illinois
$12.2M -$1.13M -35,355 -9%
KCM
31
Kornitzer Capital Management
Kansas
$12.1M +$319K +10,000 +3%
NNPTE
32
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Poland
$12M +$76K +2,380 +0.7%
Millennium Management
33
Millennium Management
New York
$11.5M +$4.13M +129,546 +62%
American Century Companies
34
American Century Companies
Missouri
$10M -$12.7K -398 -0.1%
Charles Schwab
35
Charles Schwab
California
$9.71M +$283K +8,877 +3%
Capital World Investors
36
Capital World Investors
California
$9.18M – – –
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$7.42M +$3.89M +121,800 +126%
HRCM
38
Hood River Capital Management
Florida
$7.36M -$288K -9,010 -4%
OM
39
Opaleye Management
Massachusetts
$6.98M – – –
Wellington Management Group
40
Wellington Management Group
Massachusetts
$6.83M -$15.2K -477 -0.2%
GKIM
41
GW&K Investment Management
Massachusetts
$6.6M -$124K -3,880 -2%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$5.67M +$271K +8,497 +5%
Deutsche Bank
43
Deutsche Bank
Germany
$5.09M -$46.2K -1,447 -1%
CAM
44
Cormorant Asset Management
Massachusetts
$4.91M – – –
PHS
45
PFM Health Sciences
California
$4.87M +$4.57M +143,297 New
SAM
46
Sectoral Asset Management
Quebec, Canada
$4.81M +$4.52M +141,500 New
N
47
Nuveen
North Carolina
$4.77M -$232K -7,278 -5%
Allianz Asset Management
48
Allianz Asset Management
Germany
$3.81M -$110K -3,448 -3%
FAM
49
Fred Alger Management
New York
$3.5M +$3.29M +103,148 New
AG
50
Artal Group
Luxembourg
$3.4M -$3.19M -100,000 -50%
1
2
3 4 5

DCPH Hedge Fund Activity: Q3 2021 in Review

161 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q3 2021, worth a combined $1.43B — down 8.3% from $1.56B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new DCPH positions and 12 closed out — a net gain of 15 holders — while 52 added to existing stakes and 52 trimmed.

The largest buyer was Logos Global Management, adding an estimated $23.9M. The largest seller was OrbiMed, cutting an estimated $35.6M.

  • 161 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q3 2021, up from 147 in Q2 2021.
  • Funds reported $1.43B of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q3 2021, down 8.3% quarter-over-quarter.
  • 27 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q3 2021 and 12 closed out, a net change of +15 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q3 2021 was Logos Global Management, an estimated $23.9M added.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q3 2021 was OrbiMed, an estimated $35.6M sold.

Based on aggregated 13F filings for Q3 2021.